10.1002/chem.201905576
Chemistry - A European Journal
Methyl
2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-
matic), 7.53 – 7.37 (m, 3H, aromatic,), 7.37 – 7.20 (m, 15H, aro-
matic), 7.20 – 7.10 (m, 6H, aromatic), 6.43 (dd, J3’,4’ = 9.6 Hz,
1H, H-3’), 6.01 (d, J1’,2’ = 8.3 Hz, 1H, H-1’), 5.70 (dd, 1H, H-4’),
α/β-D-mannopyranosyl)-α-D-glucopyranoside (39) was
obtained from donor 30 and acceptor 4 under the general gly-
cosylation method as a colorless foam in 98% yield (α/β =
1.3/1). Analytical data for 39 was in accordance with that pre-
2
2
5.06 (d, J = 11.2 Hz, 1H, CHPh), 4.86 (dd, J = 12.6 Hz, 2H,
CH2Ph), 4.61 (dd, J2’,3’ = 10.7 Hz, 1H, H-2’), 4.51 (dd, J6a’,6b’ = 12.0
Hz, 1H, H-6a’), 4.44 (dd, 2J = 9.0 Hz, 2H, CH2Ph), 4.40 (dd, 1H,
H-6b’), 4.38 (dd, J3’,4’ = 12.2 Hz, 1H, H-3), 4.37 (d, 1H, CHPh),
4.17 (dd, J5’,6a’ = 3.1 Hz, 1H, H-5’), 4.13 (d, J1,2 = 6.0 Hz, 1H, H-1),
Methyl 2,3,6-tri-O-benzyl-4-O-(2,3,4,6-tetra-O-benzyl-α-
D-mannopyranosyl)-α-D-glucopyranoside (40) was ob-
tained from donor 30 and acceptor 5 under the general glyco-
sylation method as a colorless foam in 98% yield. Analytical
data for 40 was in accordance with that previously reported.[51]
2
3.84 (d, J = 12.6 Hz, 1H, CHPh), 3.67-3.43 (m, 4H, H-4, 5, 6a,
6b), 3.23 (dd, J2,3 = 9.6 Hz, 1H, H-2), 3.08 (s, 3H, OCH3) ppm;
13C NMR (151 MHz, CDCl3): δ 166.3, 165.8, 165.4, 138.8, 138.5,
138.1, 133.5, 133.4, 133.0 (x8), 129.9, 129.1, 128.9, 128.6 (x3), 128.52
(x10), 128.4 (x3), 128.4 (x3), 128.3 (x2), 128.2, 128.1 (x4), 127.8,
127.6, 98.5, 97.7, 81.0, 78.7, 76.0, 74.9, 74.0, 73.6, 71.7, 71.1, 70.8,
69.6, 68.7, 63.5, 56.0, 55.0 ppm; HRMS [M+Na]+ calcd for
C63H57NO15Na 1090.3620 found 1090.3617.
Methyl 2,4,6-tri-O-benzyl-3-O-(2,3,4,6-tetra-O-benzyl-α-
D-mannopyranosyl)-α-D-glucopyranoside (41) was ob-
tained from donor 30 and acceptor 6 under the general glyco-
sylation method as a colorless foam in 98% yield. Analytical
data for 41 was in accordance with that previously reported.[52]
Methyl 2-O-(3,4,6-tri-O-benzoyl-2-deoxy-2-phthalimido-
β-D-glucopyranosyl)-3,4,6-tri-O-benzyl-α-D-glucopyra-
noside (49) was obtained from donor 43 and acceptor 7 under
the general glycosylation method using Ag2O (1.50 equiv) and
TfOH (0.50 equiv) as a colorless foam in 68% yield. Analytical
Methyl
3,4,6-tri-O-benzyl-2-O-(2,3,4,6-tetra-O-benzyl-
α/β-D-mannopyranosyl)-α-D-glucopyranoside (42) was
obtained from donor 30 and acceptor 7 under the general gly-
cosylation method as a colorless foam in 98% yield (α/β =
3.6/1). Analytical data for 42 was in accordance with that pre-
21
data for 49: Rf = 0.65 (ethyl acetate/toluene, 1/4, v/v); [α]D
1
72.1 (c 2.35, CHCl3); H NMR (300 MHz, CDCl3): δ 8.12 – 8.02
(m, 2H, aromatic), 7.94 – 7.88 (m, 2H, aromatic), 7.76 – 7.65
(m, 2H, aromatic), 7.60 – 7.08 (m, 21H, aromatic), 7.08 – 6.95
(m, 3H, aromatic), 6.84 (m, 4H, aromatic), 6.23 (dd, J3’,4’ = 9.7
Hz, 1H, H-3’), 5.84 (d, J1’,2’ = 8.4 Hz, 1H, H-1’), 5.72 (dd, J4’,5’ = 9.7
Hz, 1H, H-4’), 5.10 (d, J1,2 = 3.3 Hz, 1H, H-1), 4.77 (dd, J2’,3’ = 10.6
Hz, 1H, H-2’), 4.72 (dd, J6a’,6b’ = 11.6 Hz, 1H, H-6a’), 4.53 (dd, 2J
Methyl 6-O-(3,4,6-tri-O-benzoyl-2-deoxy-2-phthalimido-
β-D-glucopyranosyl)-2,3,4-tri-O-benzyl-α-D-glucopyra-
noside (46) was obtained from donor 42 and acceptor 4 under
the general glycosylation method using 1.0 equiv of Ag2O and
0.5 equiv of TfOH as a colorless foam in 97% yield. Analytical
data for 46 was in accordance with that previously reported.[53]
2
= 12.1 Hz, 2H, CH2Ph), 4.44 (dd, 1H, H-6b’), 4.40 (dd, J = 12.1
Hz, 2H, CH2Ph), 4.39 (s, 2H, CH2Ph), 4.28 (ddd, J5’,6a’ = 2.7 Hz,
J5’,6b’ = 5.0 Hz, 1H, H-5’), 3.85 (dd, J3,4 = 8.7 Hz, 1H, H-3), 3.73
(dd, J2,3 = 9.8 Hz, 1H, H-3), 3.72 - 3.54 (m, 3H, H-5, 6a, 6b), 3.57
(dd, J4,5 = 10.7 Hz, 1H, H-4), 3.32 (s, 3H, OCH3) ppm; 13C NMR
(151 MHz, CDCl3): δ 166.0, 165.6, 165.1, 138.5, 138.0 (x2), 133.8,
133.4, 133.2 (x2), 129.8 (x5), 129.7 (x3), 129.4, 128.8, 128.5, 128.4
(x4), 128.3 (x3), 128.2 (x2), 128.12 (x3), 127.9 (x5), 127.8 (x4),
127.6, 127.5, 126.5, 126.0 (x2), 100.1, 99.2, 82.9, 80.3, 77.7, 74.9,
74.6, 73.5, 72.2, 71.2, 69.9, 69.8, 68.5, 63.0, 55.2, 54.8; HRMS
[M+Na]+ calcd for C63H57NO15Na 1090.3620 found 1090.3615.
Methyl 4-O-(3,4,6-tri-O-benzoyl-2-deoxy-2-phthalimido-
β-D-glucopyranosyl)-2,3,6-tri-O-benzyl-α-D-glucopyra-
noside (47) was obtained from donor 42 and acceptor 5 under
the general glycosylation method using Ag2O (1.50 equiv) and
TfOH (0.50 equiv) as a colorless foam in 76% yield. Analytical
data for 47: Rf = 0.60 (ethyl acetate/toluene, 1/4, v/v); [α]D21 31.1
(c 2.05, CHCl3); 1H NMR (300 MHz, CDCl3): δ 8.04 – 7.93 (m,
2H, aromatic), 7.88 – 7.78 (m, 2H, aromatic), 7.75 – 7.69 (m,
2H, aromatic), 7.69 – 7.59 (m, 2H, aromatic), 7.55 – 7.12 (m,
26H, aromatic), 6.16 (dd, J3’,4' = 9.3 Hz, 1H, H-3’), 5.77 (d, J1’,2’
=
8.4 Hz, 1H, H-1’), 5.60 (dd, J4’,5’ = 9.7 Hz, 1H, H-4’), 4.98 (dd, 2J
= 11.8 Hz, 2H, CH2Ph), 4.60 (dd, 2J = 12.2 Hz, 2H, CH2Ph), 4.51
(dd, J2’,3’ = 10.7 Hz, 1H, H-2’) 4.50 (d, J1,2 = 3.0 Hz, 1H, H-1), 4.44
(dd, 2J = 2.7 Hz, 2H, CH2Ph), 4.34 (dd, J6a’,6b’ = 12.2, 1H, H-6a’),
4.14 (dd, 1H, H-6b’), 4.08 (dd, J4,5 = 9.2 Hz, 1H, H-4), 3.90 (dd,
J3,4 = 9.2 Hz, 1H, H-3), 3.70 – 3.53 (m, J5’,6b’ = 3.3 Hz, 2H, H-5,
5’), 3.53 – 3.47 (m, 2H, H-6a, 6b), 3.43 (dd, J2,3 = 9.5 Hz, 1H, H-
2), 3.26 (s, 3H, OCH3) ppm;13C NMR (151 MHz, CDCl3): δ 166.2,
165.9, 165.2, 139.6, 138.5, 138.4, 133.5, 133.5, 133.1, 130.0 (x6), 129.9
(x4), 129.1, 128.7, 128.5 (x12), 128.4 (x3), 128.2 (x3), 127.9, 127.6
(x3), 127.3, 127.2 (x3), 98.4, 97.6, 80.3, 79.5, 75.7, 75.0, 73.7, 73.0,
71.9, 71.4, 70.4, 69.5, 68.5, 63.2, 55.8, 55.5 ppm; HRMS [M+Na]+
calcd for C63H57NO15Na 1090.3620, found 1090.3627.
1,2:3,4-Di-O-isopropylidene-6-O-[methyl (4,7,8,9-tetra-O-
acetyl-5-(N-acetyl)acetamido-3,5-dideoxy-D-glycero-α-D-
galacto-non-2-ulo-pyranosyl)onate]-α-D-galactopyra-
nose (52) A mixture of a glycosyl donor 45[22c] (29.5 mg, 0.053
mmol), glycosyl acceptor 50 (6.8 mg, 0.026 mmol), and freshly
activated molecular sieves (3 Å, 150 mg) in CH2Cl2 (1.0 mL) was
stirred under argon for 1 h. The mixture was cooled to -78 °C,
Ag2O (24.8 mg, 0.11 mmol) was added, and the resulting
mixture was stirred for 10 min. TfOH (4.0 mg, 0.027 mmol)
was then added, and the resulting mixture was stirred under
argon for 2 h at -78 °C. After that, the reaction mixture was
allowed to warm to rt over the course of 6 h and left stirring
for additional 16 h at rt. The solid was filtered off and washed
sucessively with CH2Cl2. The combined filtrate (~40 mL) was
washed with saturated NaHCO3 (10 mL). The organic phase
was separated, dried with magnesium sulfate, and
concentrated in vacuo. The residue was purified by column
chromatography on silica gel (acetone – hexane gradient
elution) to give the title compound as a clear syrup in 97%
yield (19.6 mg, 0.025 mmol). Analytical data for 52 was in
accordance with that previously reported.[54]
Methyl 3-O-(3,4,6-tri-O-benzoyl-2-deoxy-2-phthalimido-
β-D-glucopyranosyl)-2,4,6-tri-O-benzyl-α-D-glucopyra-
noside (48) was obtained from donor 43 and acceptor 6 under
the general glycosylation method using Ag2O (1.50 equiv) and
TfOH (0.50 equiv) as a colorless foam in 72% yield. Analytical
data for 48: Rf = 0.60 (ethyl acetate/toluene, 1/4, v/v); [α]D21 6.4
(c 2.34, CHCl3); 1H NMR (300 MHz, CDCl3): δ 7.97 (m, 2H, ar-
omatic), 7.91-7.76 (m, 6H, aromatic), 7.75 – 7.64 (m, 2H, aro-
This article is protected by copyright. All rights reserved.